Task force debates certification, scope of practice and grievance processes for potential psychedelic therapies
Members debated whether the task force should be prescriptive about clinical practice, whether the Controlled Substances Advisory Committee should lead regulation, and proposed a state certification or registry for unlicensed facilitators and stronger grievance notice for patients.
The full story
The task force spent extended time discussing how Alaska should regulate clinical practice, training and oversight if psychedelic medicines gain FDA approval.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or